BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20518409)

  • 1. Risk of CIN2 in women with a pap test without endocervical cells vs. those with a negative pap test with endocervical cells: a cohort study with 4.5 years of follow-up.
    Giorgi Rossi P; Baiocchi D; Ciatto S;
    Acta Cytol; 2010; 54(3):265-71. PubMed ID: 20518409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss to follow-up of cervical smears without endocervical columnar cells is not disturbing.
    Tacken MA; Braspenning JC; Mulder J; Hermens RP; Nelen WL; de Bakker DH; Grol RP
    Eur J Gynaecol Oncol; 2006; 27(1):42-6. PubMed ID: 16550967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of endocervical curettage for detecting dysplastic lesions in women with atypical squamous cells of undetermined significance (ASC-US) and low grade squamous intraepithelial lesion (LSIL) Papanicolaou smears.
    Poomtavorn Y; Suwannarurk K; Thaweekul Y; Maireang K
    Asian Pac J Cancer Prev; 2014; 15(8):3461-4. PubMed ID: 24870740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocervical curettage in evaluating abnormal cervical cytology.
    Moniak CW; Kutzner S; Adam E; Harden J; Kaufman RH
    J Reprod Med; 2000 Apr; 45(4):285-92. PubMed ID: 10804483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's center.
    Pradhan D; Li Z; Ocque R; Patadji S; Zhao C
    Cancer Cytopathol; 2016 Aug; 124(8):589-95. PubMed ID: 27115423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears.
    Collins LC; Niloff J; Burke L; Abu-Jawdeh G; Wang H
    J Reprod Med; 2001 Feb; 46(2):105-9. PubMed ID: 11255808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF; Nygård M; Skare GB; Thoresen SO
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT; Macaluso M; Stalsberg H
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing the sensitivity of endocervical curettings by performing ThinPrep® Pap on transport container fluid: is diagnostic material going down the drain?
    Lastra RR; Meykler SE; Baloch ZW; Barroeta JE
    Cytopathology; 2015 Dec; 26(6):368-72. PubMed ID: 25123326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia.
    Huang A; Quinn M; Tan J
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):426-8. PubMed ID: 19694701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
    Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
    Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
    Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
    J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():112-116. PubMed ID: 30682600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
    Arbyn M; Buntinx F; Van Ranst M; Paraskevaidis E; Martin-Hirsch P; Dillner J
    J Natl Cancer Inst; 2004 Feb; 96(4):280-93. PubMed ID: 14970277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocervical component: is it a determinant of specimen adequacy?
    Selvaggi SM; Guidos BJ
    Diagn Cytopathol; 2002 Jan; 26(1):53-5. PubMed ID: 11782089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing visual inspection with acetic acid plus random cervical biopsy plus endocervical curettage to colposcopic directed biopsy plus endocervical curettage in detecting cervical lesions in low-resource settings.
    Puntachai P; Darojn D; Chumworathayi B; Chaousriku W
    Asian Pac J Cancer Prev; 2011; 12(10):2665-8. PubMed ID: 22320971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.